Kurzrock, R., Ball, D. W., Zahurak, M. L., Nelkin, B. D., Subbiah, V., Ahmed, S., . . . Azad, N. S. (2019). A Phase I Trial of the VEGF Receptor Tyrosine Kinase Inhibitor Pazopanib in Combination with the MEK Inhibitor Trametinib in Advanced Solid Tumors and Differentiated Thyroid Cancers. Clin Cancer Res.
Chicago ZitierstilKurzrock, Razelle, et al. "A Phase I Trial of the VEGF Receptor Tyrosine Kinase Inhibitor Pazopanib in Combination With the MEK Inhibitor Trametinib in Advanced Solid Tumors and Differentiated Thyroid Cancers." Clin Cancer Res 2019.
MLA ZitierstilKurzrock, Razelle, et al. "A Phase I Trial of the VEGF Receptor Tyrosine Kinase Inhibitor Pazopanib in Combination With the MEK Inhibitor Trametinib in Advanced Solid Tumors and Differentiated Thyroid Cancers." Clin Cancer Res 2019.